Edwards Martin

CIK 0001640073

Director

Filings

Latest Oct 8, 2025

Issuers covered

Showing

20 of 20

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Edwards Martin. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Edwards Martin has filed

Ticker	Issuer	Filings	Last filed
VRNA	Verona Pharma PLC	7	Oct 8, 2025
MORF	Morphic Holding, Inc.	6	Aug 21, 2024
RETA	Reata Pharmaceuticals Inc	4	Sep 26, 2023
INZY	Inozyme Pharma, Inc.	3	Jun 20, 2024

20 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Oct 8, 2025	VRNAVerona Pharma PLC	DDisposition	157,992	-	-
Aug 5, 2025	VRNAVerona Pharma PLC	SSale	10,808	$13.1437	$142,057
Apr 29, 2025	VRNAVerona Pharma PLC	Holdings only	-	-	-
Aug 21, 2024	MORFMorphic Holding, Inc.	DDisposition	2,376	-	-
Jun 20, 2024	INZYInozyme Pharma, Inc.	Holdings only	-	-	-
Jun 5, 2024	MORFMorphic Holding, Inc.	Holdings only	-	-	-
Apr 30, 2024	VRNAVerona Pharma PLC	Holdings only	-	-	-
Nov 22, 2023	VRNAVerona Pharma PLC	PPurchase	33,736	$1.837	$61,973
Nov 15, 2023	MORFMorphic Holding, Inc.	PPurchase	2,376	$20.54	$48,803
Sep 26, 2023	RETAReata Pharmaceuticals Inc	DDisposition	6,116	-	-
Jun 15, 2023	INZYInozyme Pharma, Inc.	Holdings only	-	-	-
Jun 9, 2023	RETAReata Pharmaceuticals Inc	AGrant	1,682	$93.61	$157,452
Jun 5, 2023	MORFMorphic Holding, Inc.	Holdings only	-	-	-
Apr 28, 2023	VRNAVerona Pharma PLC	Holdings only	-	-	-
Jun 14, 2022	INZYInozyme Pharma, Inc.	Holdings only	-	-	-
Jun 10, 2022	MORFMorphic Holding, Inc.	Holdings only	-	-	-
Jun 9, 2022	RETAReata Pharmaceuticals Inc	AGrant	3,883	$34.76	$134,973
Apr 29, 2022	VRNAVerona Pharma PLC	Holdings only	-	-	-
Apr 29, 2022	MORFMorphic Holding, Inc.A	Holdings only	-	-	-
Jan 5, 2022	RETAReata Pharmaceuticals Inc	AGrant	59	$27.32	$1,612

Showing 1-20 of 20

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.